Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$23.75 - $31.69 $370,120 - $493,856
15,584 New
15,584 $474,000
Q3 2021

Nov 12, 2021

SELL
$17.35 - $22.5 $176,015 - $228,262
-10,145 Closed
0 $0
Q2 2021

Aug 06, 2021

SELL
$18.01 - $28.32 $54,138 - $85,129
-3,006 Reduced 22.86%
10,145 $225,000
Q1 2021

May 12, 2021

SELL
$19.76 - $29.89 $547,450 - $828,102
-27,705 Reduced 67.81%
13,151 $322,000
Q4 2020

Feb 08, 2021

SELL
$15.73 - $21.66 $8,399 - $11,566
-534 Reduced 1.29%
40,856 $763,000
Q3 2020

Nov 06, 2020

BUY
$13.54 - $26.41 $82,797 - $161,497
6,115 Added 17.34%
41,390 $702,000
Q2 2020

Aug 17, 2020

BUY
$7.84 - $23.29 $182,891 - $543,309
23,328 Added 195.26%
35,275 $822,000
Q2 2020

Aug 11, 2020

SELL
$7.84 - $23.29 $122,797 - $364,791
-15,663 Reduced 56.73%
11,947 $161,000
Q1 2020

May 14, 2020

BUY
$5.57 - $11.5 $153,787 - $317,515
27,610 New
27,610 $232,000
Q4 2019

Feb 06, 2020

SELL
$7.9 - $10.14 $169,115 - $217,066
-21,407 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$9.17 - $12.01 $79,292 - $103,850
8,647 Added 67.77%
21,407 $203,000
Q2 2019

Aug 14, 2019

SELL
$10.88 - $17.6 $11,859 - $19,184
-1,090 Reduced 7.87%
12,760 $152,000
Q1 2019

May 15, 2019

BUY
$15.51 - $17.61 $40,620 - $46,120
2,619 Added 23.32%
13,850 $244,000
Q4 2018

Feb 13, 2019

BUY
$14.52 - $19.72 $163,074 - $221,475
11,231 New
11,231 $195,000
Q3 2018

Nov 08, 2018

SELL
$14.85 - $16.35 $1,588 - $1,749
-107 Closed
0 $0
Q2 2018

Aug 03, 2018

SELL
$13.8 - $16.8 $1,186 - $1,444
-86 Reduced 44.56%
107 $2,000
Q1 2018

May 11, 2018

BUY
$13.8 - $16.2 $455 - $534
33 Added 20.63%
193 $2,000
Q4 2017

Feb 08, 2018

SELL
$13.55 - $15.8 $81 - $94
-6 Reduced 3.61%
160 $2,000
Q3 2017

Nov 06, 2017

BUY
$13.45 - $14.35 $2,232 - $2,382
166
166 $2,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.